Screener
Arbutus Biopharma Corporation ABUS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $879.65M.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001447028-26-000021
FAQ
- What is Arbutus Biopharma Corporation's market capitalization?
- Arbutus Biopharma Corporation (ABUS) reported market capitalization of $879.65M in Q1 2026.
- How has Arbutus Biopharma Corporation's market capitalization changed year-over-year?
- Arbutus Biopharma Corporation's market capitalization increased by 31.6% year-over-year, from $668.27M to $879.65M.
- What is the long-term trend for Arbutus Biopharma Corporation's market capitalization?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's market capitalization has grown at a 14.0% compound annual growth rate (CAGR), from $480.21M to $925.08M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Arbutus Biopharma Corporation's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude